Glucocorticoid receptor-mediated apoptosis: mechanisms of resistance in cancer cells.
about
Direct reversal of glucocorticoid resistance by AKT inhibition in acute lymphoblastic leukemiaInvolvement of the Androgen and Glucocorticoid Receptors in Bladder CancerSelective glucocorticoid receptor-activating adjuvant therapy in cancer treatmentsEctopic microRNA-150-5p transcription sensitizes glucocorticoid therapy response in MM1S multiple myeloma cells but fails to overcome hormone therapy resistance in MM1R cellsIL-7 Receptor Mutations and Steroid Resistance in Pediatric T cell Acute Lymphoblastic Leukemia: A Genome Sequencing StudyZebrafish Expression Ontology of Gene Sets (ZEOGS): a tool to analyze enrichment of zebrafish anatomical terms in large gene sets.Enhancing circadian clock function in cancer cells inhibits tumor growthGlucocorticoid receptor knockdown decreases the antioxidant protection of B16 melanoma cells: an endocrine system-related mechanism that compromises metastatic cell resistance to vascular endothelium-induced tumor cytotoxicity.Compound A Inhibits Bladder Cancer Growth Predominantly via Glucocorticoid Receptor TransrepressionGlucocorticoid regulation of lung development: lessons learned from conditional GR knockout miceStress-dose hydrocortisone reduces critical illness-related corticosteroid insufficiency associated with severe traumatic brain injury in rats.Loss of TBL1XR1 disrupts glucocorticoid receptor recruitment to chromatin and results in glucocorticoid resistance in a B-lymphoblastic leukemia model.Bim polymorphisms: influence on function and response to treatment in children with acute lymphoblastic leukemia.Remarkable Anticancer Activity of Teucrium polium on Hepatocellular Carcinogenic RatsGlucocorticoids suppress selected components of the senescence-associated secretory phenotype.RCAN1 is an important mediator of glucocorticoid-induced apoptosis in human leukemic cells.Mining functional subgraphs from cancer protein-protein interaction networks.Synergistic Anti-Tumor Activity of EZH2 Inhibitors and Glucocorticoid Receptor Agonists in Models of Germinal Center Non-Hodgkin LymphomasHuman growth is associated with distinct patterns of gene expression in evolutionarily conserved networks.Bone marrow stroma-derived PGE2 protects BCP-ALL cells from DNA damage-induced p53 accumulation and cell deathReduced glucocorticoid receptor expression predicts bladder tumor recurrence and progression.Variegated clonality and rapid emergence of new molecular lesions in xenografts of acute lymphoblastic leukemia are associated with drug resistance.Sustained interleukin-1β exposure modulates multiple steps in glucocorticoid receptor signaling, promoting split-resistance to the transactivation of prominent anti-inflammatory genes by glucocorticoidsIntegrated analysis of DNA methylation and microRNA regulation of the lung adenocarcinoma transcriptome.Elucidating the identity of resistance mechanisms to prednisolone exposure in acute lymphoblastic leukemia cells through transcriptomic analysis: A computational approach.Prediction of tissue-specific effects of gene knockout on apoptosis in different anatomical structures of human brain.Modulation of c-Jun N-terminal kinase signaling and specific glucocorticoid receptor phosphorylation in the treatment of major depression.Using genome-wide CRISPR library screening with library resistant DCK to find new sources of Ara-C drug resistance in AMLMAPK signaling cascades mediate distinct glucocorticoid resistance mechanisms in pediatric leukemia.Cyproterone acetate enhances TRAIL-induced androgen-independent prostate cancer cell apoptosis via up-regulation of death receptor 5MicroRNAs and Glucocorticoid-Induced Apoptosis in Lymphoid MalignanciesLow SGK1 expression in human adrenocortical tumors is associated with ACTH-independent glucocorticoid secretion and poor prognosis.Cortisol and inflammatory processes in ovarian cancer patients following primary treatment: relationships with depression, fatigue, and disability.Pterostilbene Decreases the Antioxidant Defenses of Aggressive Cancer Cells In Vivo: A Physiological Glucocorticoids- and Nrf2-Dependent MechanismDual Targeting of 3-Hydroxy-3-methylglutaryl Coenzyme A Reductase and Histone Deacetylase as a Therapy for Colorectal CancerIdentification and molecular characterization of cellular factors required for glucocorticoid receptor-mediated mRNA decayCellular and urinary microRNA alterations in NZB/W mice with hydroxychloroquine or prednisone treatment.Tissue-specific actions of glucocorticoids on apoptosis: a double-edged sword.Rationale of personalized immunosuppressive medication for hepatocellular carcinoma patients after liver transplantation.The biology of depression in cancer and the relationship between depression and cancer progression.
P2860
Q24310753-29971988-6F40-4FF3-8DF6-A80A94E1968DQ26782760-C77635DF-525D-43D1-B83C-3FCE8C8F15D3Q28078896-9419CB90-854A-4FE8-8652-8DD8D8D8A465Q28542491-4521B617-06C3-458F-AE5E-E189A882766AQ28555124-26584162-CAD3-426E-96CD-2F1B925D3AE1Q30449547-7C575560-6245-46E3-B2B6-411EB7E76F07Q30838731-0D9BA1D1-E9F1-41C4-AB37-5DBFB5F1A44DQ33572974-34CB36FC-964F-45B0-B188-C16116AA125CQ33631526-C46A4EAF-1FBD-4205-8B27-1A7A1341E373Q33631785-D6E71821-3D6F-4E06-9BF5-0F152EFFB618Q33754846-9520E382-D264-4A6E-B3DD-29BDAA1BB778Q33946996-DF268FB0-7F50-48D1-B5B7-97CB4949B226Q34026481-E664FA12-86FA-406B-A11D-D02356E5099FQ34093990-4B8BED1F-203A-41A3-B674-076362F42E0CQ34190186-4A83489E-A630-4348-8AA8-83F3948E0428Q34490725-71774DDB-C55D-42A2-B11D-8510F04DA1CAQ34530412-62370BDF-4C21-47D6-99B2-F57EFF2CCB66Q34670913-3D151983-63A5-43DE-BF9B-91FCFC4D4BFBQ34938931-B8CEDE07-3288-4C92-9E1D-201177D1F250Q35068689-1CABF6D5-BFB2-486D-BCB0-AC5F4446B947Q35111955-4A7C5DAC-DD05-4BEB-8FC2-4D733EDF1562Q35467835-786F1EAF-2B08-45B6-B8AD-4AB38F2A7C4DQ35573505-1A593D9C-499D-403D-9015-C0B7F53529E5Q35805617-583215A5-60F9-4B49-8829-6815F821DFB1Q35856573-2A50E875-2A5A-4C1C-BEBA-5DB9E27C207DQ35875313-3641E8F5-8DBD-4A2E-8B0A-AB4314C8DCF3Q35995461-AFE2F843-A1EA-43A8-8E32-B7C37C066069Q36180934-53D3CDD9-9FCB-4EC0-9519-C81AD155768AQ36253975-0EEE1293-2B5C-4150-BDC3-3071F0D32EB1Q36300065-90FD64CF-099F-4639-B79E-8D18A19F23FCQ36602853-341B2016-0F95-4C83-A819-1AF4F4BB1C1DQ36631392-3B3D1750-3CF3-474F-BD6D-4A05FFD9991BQ36971577-C04A4F87-4AC8-4F42-A32A-08E72F30BF81Q37040056-A11A9B21-21BE-4A02-82BF-8030881501EBQ37221691-754738B9-E5F2-4036-B54A-B284C3A17174Q37343813-44B47FC3-18FB-45D7-BA87-61D52CABE474Q37403811-DE314B8C-DE70-41C5-9DED-4718A640F153Q37679245-CB75635C-A52E-44CF-9996-A76DC071D2A9Q38174585-40DAF8CD-E0C4-468A-AFB3-3A53A5668A26Q38203302-9CA15ED9-B749-4F14-9444-D77C8E73AAFE
P2860
Glucocorticoid receptor-mediated apoptosis: mechanisms of resistance in cancer cells.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 May 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Glucocorticoid receptor-mediated apoptosis: mechanisms of resistance in cancer cells.
@en
Glucocorticoid receptor-mediated apoptosis: mechanisms of resistance in cancer cells.
@nl
type
label
Glucocorticoid receptor-mediated apoptosis: mechanisms of resistance in cancer cells.
@en
Glucocorticoid receptor-mediated apoptosis: mechanisms of resistance in cancer cells.
@nl
prefLabel
Glucocorticoid receptor-mediated apoptosis: mechanisms of resistance in cancer cells.
@en
Glucocorticoid receptor-mediated apoptosis: mechanisms of resistance in cancer cells.
@nl
P356
P1476
Glucocorticoid receptor-mediated apoptosis: mechanisms of resistance in cancer cells.
@en
P2093
George Schlossmacher
P356
10.1530/JOE-11-0135
P407
P577
2011-05-20T00:00:00Z